What are the recommended dosing, contraindications, and safety precautions for zolpidem in adults, including considerations for elderly patients and those with hepatic impairment?

Zolpidem: Dosing, Contraindications, and Safety Precautions

Start with 5 mg in all women and elderly patients (≥65 years), and either 5 or 10 mg in adult men under 65 years, taken immediately before bedtime with at least 7-8 hours remaining before planned awakening. 1

Recommended Dosing

Standard Adult Dosing

• Women (all ages): 5 mg once nightly 1
• Men (under 65 years): 5 or 10 mg once nightly 1
  • If 5 mg is ineffective, increase to 10 mg
  • The 10 mg dose carries higher risk of next-day impairment of driving and activities requiring full alertness 1
• Maximum dose: 10 mg per night; never exceed or readminister during the same night 1

The sex-based dosing difference exists because women clear zolpidem 45% slower than men, resulting in higher blood levels and increased risk of morning impairment 1.

Special Populations

Elderly patients (≥65 years):

• 5 mg once nightly regardless of sex 1
• Elderly patients show increased sensitivity to sedative/hypnotic effects 1
• Higher doses (>10 mg) in elderly associated with 82% of falls and 78% of confusion cases in surveillance data 1

Hepatic impairment:

• Mild to moderate: 5 mg once nightly 1
• Severe hepatic impairment: Avoid zolpidem entirely—it may contribute to encephalopathy 1

Renal impairment:

• Dosage reduction is prudent, though specific FDA recommendations are not provided 2

Extended-Release and Alternative Formulations

Extended-release zolpidem:

• Adults: 6.25 mg (reduced from previous 12.5 mg recommendation) 3
• Elderly: 6.25 mg 3
• Provides sleep maintenance benefits beyond 6 hours 3

Sublingual formulations:

• Low-dose sublingual (3.5-5 mg): For middle-of-the-night awakenings 4, 5
• Standard-dose sublingual (10 mg): For sleep onset difficulty 5

Clinical Efficacy

Zolpidem demonstrates moderate-strength evidence for:

• Sleep onset: Reduces sleep latency by 15-18 minutes versus placebo 4, 3
• Sleep maintenance: Increases total sleep time by 23-48 minutes 4, 3
• Sleep quality: Moderately large improvements on standardized measures 3

The American Academy of Sleep Medicine provides a WEAK recommendation for zolpidem use in both sleep onset and sleep maintenance insomnia 3. This weak recommendation reflects very low overall quality of evidence due to heterogeneity, imprecision, and publication bias 3.

Critical Safety Precautions

Next-Day Impairment

• Most important safety concern: Morning blood levels sufficient to impair driving and activities requiring full alertness 1
• Risk is dose-dependent and higher with 10 mg dose 1
• Ensure minimum 7-8 hours between dosing and awakening 1
• Women and elderly at highest risk due to slower clearance 1

Neuropsychiatric Adverse Effects

Common adverse effects (dose-related):

• Amnesia, dizziness, somnolence 3
• Nausea, headache, altered taste 3
• Hallucinations (particularly in pediatric patients—7% incidence) 1

Complex sleep behaviors:

• Sleep-driving, sleep-eating, sleep-walking 4, 6, 7
• Often unrecognized by patient 6
• Can result in serious personal injury and legal consequences 6
• Risk increases with higher doses and psychiatric comorbidities 6

High-Risk Populations

Increased adverse event risk in:

• Women (slower clearance) 1
• Elderly (increased sensitivity, falls, confusion) 1
• Patients with psychiatric comorbidities 6
• Those on polypharmacy 6

Specific risks in elderly:

• Falls: 1.5% incidence, 93% in patients ≥70 years 1
• Fractures: Adjusted odds ratio 1.72 (95% CI: 1.37-2.16) 4
• Confusion: 1.2% incidence, 75% in patients ≥70 years 1

Drug Interactions

CNS depressants:

• Dosage adjustment necessary when combined with other CNS depressants due to additive effects 1
• Increased risk of respiratory depression when combined with opioids 1

No significant interactions with:

• Haloperidol, cimetidine, ranitidine, chlorpromazine, warfarin, digoxin, flumazenil 2

Caution with:

• Imipramine: May cause anterograde amnesia 2

Administration Considerations

• Take on empty stomach—food slows absorption and reduces effectiveness 1
• Single dose only per night; never readminister 1
• Discontinue if patient does not get 7-8 hours of sleep opportunity 1

Contraindications and Avoidance

Absolute contraindications:

• Severe hepatic impairment (risk of encephalopathy) 1

Not recommended:

• Pediatric patients (<18 years): No established safety or efficacy; high hallucination risk (7%) 1
• Pregnancy/lactation: Consider interrupting breastfeeding for 23 hours (5 half-lives) after dose 1

Tolerance, Dependence, and Withdrawal

Favorable profile when used as recommended:

• No evidence of tolerance in studies up to 6 months 8
• Low potential for abuse compared to benzodiazepines 8, 9
• Minimal rebound insomnia upon discontinuation 8, 9
• No significant withdrawal symptoms at recommended doses 8

However:

• Tolerance reported in patients using high doses for extended periods 8
• Continuous use associated with higher adverse event rates 7
• In cirrhosis patients, deprescribing zolpidem reduces falls (23.2% vs 31%) and fractures (21% vs 29%) 10

Clinical Pitfalls to Avoid

1. Do not prescribe 10 mg to women or elderly—use 5 mg maximum 1
2. Do not ignore the 7-8 hour sleep requirement—shorter sleep periods increase next-day impairment 1
3. Do not combine with alcohol or other CNS depressants without dose adjustment 1
4. Do not use in severe hepatic impairment 1
5. Do not assume safety in continuous long-term use—reassess regularly, particularly in elderly 7, 10
6. Do not overlook complex sleep behaviors—counsel patients and caregivers about this risk 6